Skip to main content
P0292 / #1639: PEDIATRIC SEPSIS INTERVENTIONS AND IN-HOSPITAL MORTALITY IN A RESOURCE-LIMITED EMERGENCY MEDICINE DEPARTMENT.
O010 / #378: STANDARDIZATION OF PREDICTORS FOR STUDIES OF PAEDIATRIC SEPSIS.
Renal Recovery and Mortality Risk among Patients with Hepatorenal Syndrome Receiving Chronic Maintenance Dialysis.
Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma.
122 Safety and Efficacy Outcomes in Pediatric Patients with Transfusion-Dependent ß-Thalassemia (TDT) Receiving Betibeglogene Autotemcel (beti-cel; LentiGlobin for ß-thalassemia) Gene Therapy in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3
1 Efficacy and Safety of Betibeglogene Autotemcel (beti-cel; LentiGlobin for ß-thalassemia) Gene Therapy in 60 Patients with Transfusion-Dependent ß-Thalassemia (TDT) Followed for up to 6 Years Post-Infusion.
A multi-ethnic genome-wide association study implicates collagen matrix integrity and cell differentiation pathways in keratoconus.
149 Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion Following Loss of B-Cell Aplasia in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia: HESTER Phase II Study.
Late Kidney Morbidity and Mortality in Hematopoietic Cell Transplant Survivors.
Mother & Baby Substance Exposure Toolkit; Best Practice #29- Develop a Dyad-centered Plan of Safe Care